Literature DB >> 11067858

RNA-transfected dendritic cells in cancer immunotherapy.

D A Mitchell1, S K Nair.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11067858      PMCID： PMC301423          DOI： 10.1172/JCI11405

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  31 in total

1.  Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells.

Authors:  D Boczkowski; S K Nair; J H Nam; H K Lyerly; E Gilboa
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

2.  In vitro sensitization of the B16 murine melanoma cells to ganciclovir by different RNA and plasmid DNA constructions encoding HSVtk.

Authors:  S V Yarovoi; R Mouawad; F Colbère-Garapin; C Soubrane; D Khayat; O Rixe
Journal:  Gene Ther       Date:  1996-10       Impact factor: 5.250

3.  Delivery of liposome-encapsulated RNA to cells expressing influenza virus hemagglutinin.

Authors:  J S Glenn; H Ellens; J M White
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

4.  Shaping the repertoire of cytotoxic T-lymphocyte responses: explanation for the immunodominance effect whereby cytotoxic T lymphocytes specific for immunodominant antigens prevent recognition of nondominant antigens.

Authors:  S Pion; G J Christianson; P Fontaine; D C Roopenian; C Perreault
Journal:  Blood       Date:  1999-02-01       Impact factor: 22.113

5.  Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

Authors:  S K Nair; D Boczkowski; M Morse; R I Cumming; H K Lyerly; E Gilboa
Journal:  Nat Biotechnol       Date:  1998-04       Impact factor: 54.908

6.  Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells.

Authors:  E Manickan; S Kanangat; R J Rouse; Z Yu; B T Rouse
Journal:  J Leukoc Biol       Date:  1997-02       Impact factor: 4.962

7.  Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA.

Authors:  F Martinon; S Krishnan; G Lenzen; R Magné; E Gomard; J G Guillet; J P Lévy; P Meulien
Journal:  Eur J Immunol       Date:  1993-07       Impact factor: 5.532

8.  Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors.

Authors:  D M Ashley; B Faiola; S Nair; L P Hale; D D Bigner; E Gilboa
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

9.  Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.

Authors:  P Paglia; C Chiodoni; M Rodolfo; M P Colombo
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

10.  Proliferating dendritic cell progenitors in human blood.

Authors:  N Romani; S Gruner; D Brang; E Kämpgen; A Lenz; B Trockenbacher; G Konwalinka; P O Fritsch; R M Steinman; G Schuler
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307
View more
  30 in total

1.  Validation of efficient high-throughput plasmid and siRNA transfection of human monocyte-derived dendritic cells without cell maturation.

Authors:  Robert Bowles; Sonali Patil; Hanna Pincas; Stuart C Sealfon
Journal:  J Immunol Methods       Date:  2010-09-24       Impact factor: 2.303

Review 2.  Toward effective immunotherapy for the treatment of malignant brain tumors.

Authors:  Duane A Mitchell; John H Sampson
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

3.  Optimized protocol for efficient transfection of dendritic cells without cell maturation.

Authors:  Robert Bowles; Sonali Patil; Hanna Pincas; Stuart C Sealfon
Journal:  J Vis Exp       Date:  2011-07-08       Impact factor: 1.355

4.  Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients.

Authors:  An M T Van Nuffel; Daphné Benteyn; Sofie Wilgenhof; Lauranne Pierret; Jurgen Corthals; Carlo Heirman; Pierre van der Bruggen; Pierre G Coulie; Bart Neyns; Kris Thielemans; Aude Bonehill
Journal:  Mol Ther       Date:  2012-02-28       Impact factor: 11.454

5.  Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8(+) T cell responses in children with NPM-ALK(+) anaplastic large cell lymphoma.

Authors:  V K Singh; S Werner; H Hackstein; V Lennerz; A Reiter; T Wölfel; C Damm-Welk; W Woessmann
Journal:  Clin Exp Immunol       Date:  2016-08-16       Impact factor: 4.330

6.  Dendritic cells transfected with hepatocellular carcinoma (HCC) total RNA induce specific immune responses against HCC in vitro and in vivo.

Authors:  B H Xie; J Y Yang; H P Li; B Zhang; W Chen; B Zhou; B G Peng; L J Liang; Q He
Journal:  Clin Transl Oncol       Date:  2013-12-12       Impact factor: 3.405

7.  Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules.

Authors:  Maria R Parkhurst; Cormac DePan; John P Riley; Steven A Rosenberg; Suyu Shu
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

8.  An effective cancer vaccine modality: lentiviral modification of dendritic cells expressing multiple cancer-specific antigens.

Authors:  Bei Wang; Jin He; Chen Liu; Lung-Ji Chang
Journal:  Vaccine       Date:  2006-02-28       Impact factor: 3.641

9.  Comparative analysis of cytotoxic T lymphocyte response induced by dendritic cells loaded with hepatocellular carcinoma -derived RNA or cell lysate.

Authors:  Ke Pan; Jing-jing Zhao; Hui Wang; Jian-jun Li; Xiao-ting Liang; Jian-cong Sun; Yi-bing Chen; Hai-qing Ma; Qing Liu; Jian-chuan Xia
Journal:  Int J Biol Sci       Date:  2010-10-13       Impact factor: 6.580

10.  Dendritic cell mediated delivery of plasmid DNA encoding LAMP/HIV-1 Gag fusion immunogen enhances T cell epitope responses in HLA DR4 transgenic mice.

Authors:  Gregory G Simon; Yongli Hu; Asif M Khan; Jingshi Zhou; Jerome Salmon; Priya R Chikhlikar; Keun-Ok Jung; Ernesto T A Marques; J Thomas August
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.